2023-2024 Regular Session • US Congress Legislature
HB5958: Drug-price Transparency for Consumers Act of 2023
Legislative Summary
To amend title XI of the Social Security Act to require that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information.
Bill History
10/13/2023
Introduced in House
House of Representatives
10/25/2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
House of Representatives
12/17/2024
Referred to the Subcommittee on Health.
House of Representatives
Status Information
Current Status
Introduced(10/13/2023)
Chamber
House of Representatives
Committee
Subcommittee on Health(House of Representatives)
